Novogen Limited (KZIA)
(Real Time Quote from BATS)
$8.76 USD
+0.08 (0.92%)
Updated Aug 6, 2025 03:31 PM ET
After-Market: $8.76 0.00 (0.00%) 4:06 PM ET
3-Hold of 5 3
F Value A Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Novogen Limited has a market cap of $8.74M, which represents its share price of $8.68 multiplied by its outstanding shares number of 1.01M. As a small-cap company, KZIA's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
KZIA 8.76 +0.08(0.92%)
Will KZIA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for KZIA based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for KZIA
Kazia Therapeutics (KZIA) Secures $2M in Private Equity Placement
Kazia Therapeutics Announces $2 Million Private Placement at Premium to Market | KZIA Stock News
12 Health Care Stocks Moving In Friday's Pre-Market Session
Kazia Therapeutics announces $2M private placement
KZIA: Kazia Therapeutics Price Target Raised to $13 by HC Wainwright & Co. | KZIA Stock News